LifeShare Blood Center (LifeShare) is proud to announce the creation of LifeShare Biologics (BLX), a subsidiary. “LifeShare’s Board of Trustees is committed to positioning the organization to meet the rising demand for cellular therapy as a strategic path to expand our mission,ˮ says Walt Sanchez, LifeShare Biologicsʼ Chair. LifeShareʼs Board recognizes the increasing applications of specialized medicine like stem cells and other biologically sourced materials. “We are creating an organization uniquely positioned to focus on, and create access to, cellular applications in research and medicine,ˮ says Dr. Chad A. Douglas, LifeShareʼs President & CEO. READ MORE
